Analog-sensitive cell line identifies cellular substrates of CDK9

Tim-Michael Decker; Ignasi Forné; Tobias Straub; Hesham Elsaman; Guoli Ma; Nilay Shah; Axel Imhof; Dirk Eick

doi:10.18632/oncotarget.27334

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Analog-sensitive cell line identifies cellular substrates of CDK9

Tim-Michael Decker _, Ignasi Forné, Tobias Straub, Hesham Elsaman, Guoli Ma, Nilay Shah, Axel Imhof and Dirk Eick _

PDF | Full Text | Supplementary Files | How to cite

Oncotarget. 2019; 10:6934-6943. https://doi.org/10.18632/oncotarget.27334

Metrics: PDF 1252 views | Full Text 3053 views | ?

Abstract

Tim-Michael Decker1^,4, Ignasi Forné2, Tobias Straub3, Hesham Elsaman1, Guoli Ma1, Nilay Shah1^,5, Axel Imhof2 and Dirk Eick1

1 Department of Molecular Epigenetics, Helmholtz Center Munich and Center for Integrated Protein Science Munich (CIPSM), Germany

2 Biomedical Center Munich, ZFP, Ludwig-Maximilian University Munich, Germany

3 Bioinformatic Unit, Biomedical Center Munich, Ludwig-Maximilian University Munich, Planegg-Martinsried, Germany

4 Present address: Department of Biochemistry, University of Colorado, Boulder, USA

5 Present address: Stowers Institute for Medical Research, Kansas City, Missouri, USA

Correspondence to:

Tim-Michael Decker,	email:	[email protected]
Dirk Eick,	email:	[email protected]

Keywords: CDK9; protein kinase; transcription; RNA splicing; phosphoproteomics

Received: September 12, 2019 Accepted: November 07, 2019 Published: December 10, 2019

ABSTRACT

Transcriptional cyclin-dependent kinases regulate all phases of transcription. Cyclin-dependent kinase 9 (CDK9) has been implicated in the regulation of promoter-proximal pausing of RNA polymerase II and more recently in transcription termination. Study of the substrates of CDK9 has mostly been limited to in vitro approaches that lack a quantitative assessment of CDK9 activity. Here we analyzed the cellular phosphoproteome upon inhibition of CDK9 by combining analog-sensitive kinase technology with quantitative phosphoproteomics in Raji B-cells. Our analysis revealed the activity of CDK9 on 1102 phosphosites quantitatively, and we identified 120 potential cellular substrates. Furthermore, a substantial number of CDK9 substrates were described as splicing factors, highlighting the role of CDK9 in transcription-coupled splicing events. Based on comparison to in vitro data, our findings suggest that cellular context fundamentally impacts the activity of CDK9 and specific selection of its substrates.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 27334

Publication Alerts

Research Papers:

Analog-sensitive cell line identifies cellular substrates of CDK9

Abstract